Huntsville Hospital
Approved Hospital Formulary
Suggestions or Corrections?
Above and Beyond Nominations
Formulary Request
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Formulary
Restricted
Non-formulary
Therapeutic Interchange
Black Box Warning
HAZ-MED
Chemotherapy
Formulary, Not Routinely Stocked
Patient Fact Sheets
Hormonal Therapy
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
News
Boards
Medications not yet evaluated by P&T are considered
NON-FORMULARY
. . . . . Always check 2 unique patient identifiers -
NAME
and
DATE OF BIRTH
- at every step! . . . . .
Please be sure to document all clinical activities daily.
Huntsville Hospital
Approved Hospital Formulary
Suggestions or Corrections?
Above and Beyond Nominations
Formulary Request
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Formulary
Restricted
Non-formulary
Therapeutic Interchange
Black Box Warning
HAZ-MED
Chemotherapy
Formulary, Not Routinely Stocked
Patient Fact Sheets
Hormonal Therapy
Webpage Links
Search results for:
glucagon
glucagon
Formulary
Non-formulary
Drug Name
Form
Strength
Formulary Unrestricted
Formulary Restricted
Non-Formulary
Interchange
Baqsimi
DEVICE, NASAL
3 mg
GVOKE
INJECTION, SUBCUTANEOUS
0.5 mg/0.1 mL, 1 mg/0.2 mL
GlucaGen
POWDER FOR INJECTION, INJECTABLE
recombinant 1 mg
VIEW MORE
Glycogenolytic Agents
CLASS
682212
Comments:
GVOKE:
Automatic interchange to GlucaGen.
Reviewed:
May 2021 (GVOKE)
,
Nov. 2021 (Baqsimi)
Last updated:
Dec. 1, 2021
Micromedex
UpToDate
Lippincott Advisor
GVOKE: Automatic interchange to GlucaGen.
Reviewed: May 2021 (GVOKE), Nov. 2021 (Baqsimi)